European journal of nuclear medicine and molecular imaging
RECIP 1.0 more predictive of overall survival than PSMA PET progression criteria in biochemically recurrent prostate cancer.
Kaylee Molin, Jeremy S L Ong, Steven Van Der Werf, Roslyn J Francis, Ghulam Mubashar Hassan, Martin A Ebert, Jake Kendrick
Published: 202510.1007/s00259-025-07592-6
Abstract
PURPOSE: Up to 40% of prostate cancer (PCa) patients experience biochemical recurrence (BCR) after primary treatment, but reliable tools for risk stratification in this setting are limited. This study compared Response Evaluation Criteria in PSMA PET…
Preview only. Read the full abstract at the source